Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma

Table 2

Cases discontinued after the switch to fixed-combination eye drops.

	Group 1	Group 2	𝑃
IOP decreasing efficacy; Glaucoma surgery conducted	20.0%; (11 cases)	24.6%; (14 cases)	0.6522
Adverse reactions	7.3%; (4 cases)	14.0%; (8 cases)	0.3612
Classification of adverse reactions	Eye irritation; 1 case	Blurred vision; 3 cases
	Itchiness; 1 case	Eye irritation; 3 cases
	Foreign body sensation; 1 case	Chest pain; 1 case
	Superficial punctate keratopathy; 1 case	Asthma attack; 1 case